背景:哮喘是一种慢性呼吸系统疾病,需要长期药物治疗和患者授权来控制病情并识别和应对哮喘加重。移动健康(mHealth)应用程序代表了一种潜在的媒介,通过这种媒介,患者可以提高他们自我管理哮喘的能力。很少有研究使用经过验证的工具对哮喘移动应用程序的质量和功能进行系统评估。这些评论都没有系统地评估这些应用程序的内容,并根据可用的国际最佳实践指南进行评估。
目的:本研究的目的是对成人靶向哮喘mHealth应用程序进行系统的搜索和评估。作为这次审查的一部分,将使用移动应用程序评分量表框架评估mHealth应用程序改善哮喘自我管理和应用程序整体质量的潜力,应用程序中的信息质量将使用当前的全球哮喘倡议指南作为参考进行评估。
方法:在创建本综述时采用了逐步的方法学方法。首先,2位作者对最新的全球哮喘倡议指南进行了独立审查,以确定可以可行地纳入mHealth应用程序的关键建议.确定了以前开发的哮喘评估框架,并对其进行了修改,以适应我们的研究,并确保包括所有已确定的建议。总的来说,对2个受欢迎的应用商店进行了审查,以确定潜在的mHealth应用。这些应用程序是根据预定义的纳入和排除标准进行筛选的。然后评估合适的应用程序。技术信息是从公开信息中获得的。下一步是使用经过验证的移动应用程序评级量表框架执行应用程序质量评估,以客观地确定应用程序的质量。使用洲际医学统计学健康信息学功能评分系统评估应用程序功能。最后,使用我们开发的检查表评估了mHealth应用程序.
结果:已收到北方卫生部呼吸科的资助,维多利亚已经招募了三名审稿人来系统地评估这些应用程序。这项研究的结果预计在2022年。
结论:据我们所知,这篇综述代表了第一项研究,以检查澳大利亚所有针对哮喘成人的mHealth应用程序的功能,质量,并与国际最佳实践准则保持一致。虽然这项审查只会在澳大利亚提供的mHealth应用程序上进行,许多应用程序在全球范围内可用;因此,这项研究应该在很大程度上推广到其他讲英语的地区和用户。这篇综述的结果将有助于填补文献中的空白,并帮助临床医生为希望使用mHealth应用程序作为哮喘自我管理一部分的患者提供循证建议。
背景:PROSPERO269894;https://www.crd.约克。AC.uk/prospro/display_record.php?RecordID=269894。
未经批准:PRR1-10.2196/33103。
BACKGROUND: Asthma is a chronic respiratory disorder that requires long-term pharmacotherapy and patient empowerment to manage the condition and recognize and respond to asthma exacerbations. Mobile health (mHealth) apps represent a potential medium through which patients can improve their ability to self-manage their asthma. Few studies have conducted a systematic evaluation of asthma mobile apps for quality and functionality using a validated tool. None of these reviews have systematically assessed these apps for their content and evaluated them against the available international best practice
guidelines.
OBJECTIVE: The objective of this study is to conduct a systematic search and evaluation of adult-targeted asthma mHealth apps. As part of this review, the potential of an mHealth app to improve asthma self-management and the overall quality of the app will be evaluated using the Mobile App Rating Scale framework, and the quality of the information within an app will be evaluated using the current Global Initiative for Asthma
guidelines as a reference.
METHODS: A stepwise methodological approach was taken in creating this review. First, the most recent Global Initiative for Asthma
guidelines were independently reviewed by 2 authors to identify key recommendations that could be feasibly incorporated into an mHealth app. A previously developed asthma assessment framework was identified and was modified to suit our research and ensure that all of these identified recommendations were included. In total, 2 popular app stores were reviewed to identify potential mHealth apps. These apps were screened based on predefined inclusion and exclusion criteria. Suitable apps were then evaluated. Technical information was obtained from publicly available information. The next step was to perform an app quality assessment using the validated Mobile App Rating Scale framework to objectively determine the quality of an app. App functionality was assessed using the Intercontinental Medical Statistics Institute for Health Informatics Functionality Scoring System. Finally, the mHealth apps were assessed using our developed checklist.
RESULTS: Funding has been received for the project from the Respiratory Department at Northern Health, Victoria. Three reviewers have been recruited to systematically evaluate the apps. The results of this study are expected in 2022.
CONCLUSIONS: To our knowledge, this review represents the first study to examine all mHealth apps available in Australia that are targeted to adults with asthma for their functionality, quality, and consistency with international best practice
guidelines. Although this review will only be conducted on mHealth apps available in Australia, many apps are available worldwide; thus, this study should be largely generalizable to other English-speaking regions and users. The results of this review will help to fill gaps in the literature and assist clinicians in providing evidence-based advice to patients wishing to use mHealth apps as part of their asthma self-management.
BACKGROUND: PROSPERO 269894; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=269894.
UNASSIGNED: PRR1-10.2196/33103.